About Suvoda
Suvoda news and updates
Suvoda launched eConsent and eCOA solutions on Mar 7th 22'.
Suvoda announced the release of its eConsent and eCOA solutions—now in early adopter phase—marking a critical step in Suvoda's path to streamline complex clinical trials.
Jan 1, 2022 | newswire.caSuvoda hired Andrew McVeigh as Chief Financial Officer on Jan 1st 21'.
Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas such as oncology, central nervous system (CNS) and rare disease, today announced the broadening of its leadership team with the additions of Andrew McVeigh as Chief Architect and Steve DeSantis as Chief Financial Officer.
Jan 1, 2022 | yahoo.comSuvoda launched eConsent on May 19th 22'.
Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas such as oncology, central nervous system (CNS), and rare disease, today announced the broad availability of eConsent as part of its unified platform, providing a simplified solution that gives clinical trial teams more electronic control over the consent process.
Jan 1, 2022 | prnewswire.comSuvoda hires Jill Platko as vice president of scientific services
Suvoda LLC – Industry veteran Jill Platko was named vice president of scientific services at Suvoda, a clinical trial technology company.
Jan 1, 2022 | biospace.comSuvoda launches IRT software
When Suvoda introduced its IRT software, Suvoda acknowledged sponsor challenges, empathized with their day to day needs, and provided an immediate solution that could change and evolve over time.
Oct 18, 2022 | suvoda.com